Safety Shot Inc. Files S-1 for Public Offering

Ticker: BNKK · Form: S-1 · Filed: Feb 4, 2025 · CIK: 1760903

Safety Shot, INC. S-1 Filing Summary
FieldDetail
CompanySafety Shot, INC. (BNKK)
Form TypeS-1
Filed DateFeb 4, 2025
Risk Levelmedium
Pages15
Reading Time18 min
Key Dollar Amounts$0, $1.75 million, $3.5 million, $0.4348, $0.45
Sentimentneutral

Sentiment: neutral

Topics: s-1, registration-statement, public-offering

TL;DR

Safety Shot Inc. is filing an S-1 to sell shares to the public.

AI Summary

Safety Shot, Inc. filed an S-1 registration statement with the SEC on February 4, 2025, to register securities for public sale. The company, headquartered in Jupiter, Florida, is offering its shares on a delayed or continuous basis. Jarrett Boon is the Chief Executive Officer and agent for service.

Why It Matters

This S-1 filing indicates Safety Shot, Inc. is preparing to offer its securities to the public, which could impact its capital structure and shareholder base.

Risk Assessment

Risk Level: medium — S-1 filings often precede significant corporate actions like public offerings, which carry inherent market risks.

Key Players & Entities

FAQ

What is the purpose of this S-1 filing?

The purpose of this S-1 filing is to register securities for a proposed sale to the public, which may occur on a delayed or continuous basis.

When was this registration statement filed with the SEC?

This registration statement was filed with the U.S. Securities and Exchange Commission on February 4, 2025.

Who is the Chief Executive Officer of Safety Shot, Inc.?

Jarrett Boon is the Chief Executive Officer of Safety Shot, Inc.

Where are Safety Shot, Inc.'s principal executive offices located?

Safety Shot, Inc.'s principal executive offices are located at 1061 E. Indiantown Rd., Ste. 110, Jupiter, FL 33477.

Who is providing legal counsel for this registration?

Arthur S. Marcus, Esq. from Sichenzia Ross Ference Carmel LLP is providing legal counsel for this registration.

Filing Stats: 4,458 words · 18 min read · ~15 pages · Grade level 15.3 · Accepted 2025-02-04 16:32:48

Key Financial Figures

Filing Documents

USE OF PROCEEDS

USE OF PROCEEDS 29 DETERMINATION OF OFFERING PRICE 29 DIVIDEND POLICY 29 MARKET INFORMATION 30

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 30

BUSINESS

BUSINESS 41 MANAGEMENT 51

EXECUTIVE COMPENSATION

EXECUTIVE COMPENSATION 57 CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS 60 PRINCIPAL STOCKHOLDERS 60 SELLING STOCKHOLDERS 61

DESCRIPTION OF SECURITIES

DESCRIPTION OF SECURITIES 61 PLAN OF DISTRIBUTION 68 LEGAL MATTERS 69 EXPERTS 69 INDEX TO FINANCIAL STATEMENTS F-1 i ABOUT THIS PROSPECTUS This prospectus is a part of a registration statement that we have filed with the U.S. Securities and Exchange Commission (the "SEC" or the "Commission"), pursuant to which the Selling Stockholders named herein may, from time to time, offer and sell or otherwise dispose of the shares of our common stock covered by this prospectus. This prospectus and the documents incorporated by reference into this prospectus include important information about us, the securities being offered and other information you should know before investing in our common stock. Before purchasing any common stock, you should carefully read both this prospectus and any applicable prospectus supplement, together with the additional information described under the heading "Where You Can Find More Information" and "Incorporation of Certain Information by Reference." Neither we, nor the Selling Stockholders, have authorized anyone to provide you with any information or to make any representations other than those contained in this prospectus or in any applicable prospectus supplement prepared by or on behalf of us or to which we have referred you. We and the Selling Stockholders take no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. The Selling Stockholders will not make an offer to sell these securities in any jurisdiction where the offer or sale is not permitted. You should assume that the information appearing in this prospectus and in any applicable prospectus supplement to this prospectus is accurate only as of the date on its respective cover, that the information appearing in any applicable free writing prospectus is accurate only as of the date of that free writing prospectus, and that any information incorporated by reference is accurate only as of the da

forward-looking statements

forward-looking statements. Should one or more of the risks or uncertainties described above or elsewhere in this prospectus occur, or should underlying assumptions prove incorrect, our actual results and plans could differ materially from those expressed in any forward-looking statements. Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date they are made. Except as required by law, we disclaim all responsibility to publicly update any information contained in a forward-looking statement or any forward-looking statement. All forward-looking statements attributable to us or to persons acting on our behalf, including any such forward-looking statements made subsequent to the publication of this prospectus, are expressly qualified in their entirety by this cautionary statement. 3 PROSPECTUS SUMMARY This summary highlights information contained elsewhere or incorporated by reference into this prospectus. Because it is a summary, it does not contain all of the information that you should consider before investing in our common stock. You should read this entire prospectus carefully, including the section entitled "Risk Factors," any applicable prospectus supplement and the documents that we incorporate by reference into this prospectus and any applicable prospectus supplement, before making an investment decision. Overview Safety Shot Inc. (NASDAQ: SHOT) was formerly known as Jupiter Wellness Inc. In August 2023, the Company successfully completed the asset purchase of the Safety Shot Dietary Supplement from GBB Drink Lab, Inc. ("GBB"), thereby gaining ownership of various assets, including the intellectual property, trade secrets, and trademarks associated with its dietary supplement (the "Safety Shot Dietary Supplement"). Concurrently with the asset purchase, the Company changed its name to Safety Shot, Inc. and changed its NASDAQ trading symbol to SHOT. The Company launched its e-commerce sale o

View Full Filing

View this S-1 filing on SEC EDGAR

View on Read The Filing